Cellular support
Stem cells (MSCs) are considered to support vessels and nervous tissue.
Cellular medicine · nervous system
Neuroregeneration — supporting recovery of the nervous system
Neuroregeneration is part of comprehensive rehabilitation, not a stand-alone procedure. The plan is set by a multidisciplinary team (MDT) and may include MSC therapy, peptide complexes and neuro-infusions. It is used strictly by indication. In acute conditions, specialist emergency care comes first.
- Part of comprehensive rehabilitation
- Plan set by an MDT
- By neurological diagnostics
- Strictly by indication
About the method
What is Neuroregeneration
The nervous system recovers slowly, and no single method manages this alone. So a whole programme is assembled here: MSC therapy, peptide complexes and neuro-infusions work together with rehabilitation, supporting the body's own recovery processes.
The programme is always built individually by a multidisciplinary team (MDT) on the basis of neurological diagnostics.
It is always part of comprehensive rehabilitation. Acute and severe conditions require specialist emergency medical care first.
How it works
The principle
Peptide complexes
Support and protection of nerve cells (neuroprotection) and metabolism — as assessed by a physician.
Rehabilitation
Strengthens the programme's effect and consolidates the result.
Scientific basis
Origin and scientific basis
Facts about the method's origin, standards and quality control — what trust is built on. This is not a promise of a result: a physician decides whether it's right for you.
- An active research area
Neuroregenerative cellular approaches are an actively studied area of recovery medicine.
- Strict indications
Used on strict indications and by the decision of a specialist MDT.
- Linked to rehabilitation
Combined with the programmes of the hospital's neurorehabilitation centre.
The team
Specialist physicians for this area
This area in the cluster is led by specialist physicians with years of experience and academic credentials. They prescribe and deliver the treatment — MedBridge coordinates your route.
Wang JunchengRegenerative medicine · vascular surgeryDeputy chief physician; a graduate of Zhejiang University, a “highly qualified specialist” of Hainan (2019). Experience with LaViv, PRP, stem and immune cells for joint, nervous-system and anti-age recovery.
Who it's for
This may be relevant to you
Most people who consider this method recognise themselves in situations like these. It's not a prompt for self-treatment — whether it fits your case is decided by a physician after consultation and diagnostics.
- Recovery after stroke
You've passed the acute stage and want a coherent recovery programme.
- After nervous-system injury
You're looking for a comprehensive approach and a team of specialists for your case.
- Reduced memory and concentration
You notice cognitive changes and want to address them properly, through diagnostics.
- Diabetic neuropathy
You want to consider cellular support within a programme — as assessed by a physician.
- Ready to invest in the outcome
You understand that recovery takes time, a setting and support, and you want all of it in one place.
Why patients consider it
Why patients consider this method
These are reasons for interest in the method, not a promise of outcome: the physician sets the final decision and realistic expectations.
- A programme and a team
Cellular methods work in tandem with rehabilitation — that's how progress is built and consolidated.
- Decided by an MDT
The plan is assembled by a team of relevant specialists on the basis of neuro-diagnostics — for your case.
- Setting and access
The technologies of the Boao Lecheng zone and the calm climate of Hainan for a long recovery.
- Full support
A personal coordinator, interpreting, logistics and oversight at every stage — you're not alone in an unfamiliar system.
Indications
When it may be considered
May be considered by a physician within recovery programmes. Suitability is determined individually after diagnostics; acute conditions require specialist care.
- Recovery after stroke
- After nervous-system injury
- Cognitive impairment, reduced memory and concentration
- Diabetic neuropathy — as assessed by a physician
- Neurodegenerative conditions — only by an individual specialist assessment
Safety
Standards and quality control
The approach is built around patient safety and verifiable quality.
- Certified clinics of the Boao Lecheng medical cluster
- Laboratory and protocols to international GMP / ISO standards
- Multi-stage control: sterility, viability and cell activity
- Outpatient, without hospitalisation, under the supervision of relevant specialists
Process
How it goes
- 1Neuro-diagnostics
Neurological examination, MRI/CT, cognitive tests, lab work.
- 2MDT review
Drawing up an individual programme plan.
- 3Cell preparation
Collection and culture to GMP standards.
- 4Administration
Intravenously or locally, by protocol.
- 5Rehabilitation
As part of a comprehensive programme.
- 6Follow-up
Check-up in 2–4 weeks.
A course is usually 4–6 weeks, with 1–3 cell administrations within rehabilitation. The result is individual, depends on the starting state and is not guaranteed; the physician assesses dynamics.
Outcomes
What to expect, and how progress is assessed
- A marathon, not a sprint
Recovery proceeds over weeks and months, within rehabilitation; the method promises no quick results.
- Assessed by the MDT
Dynamics are tracked with neurological and cognitive tests, examinations and MDT oversight.
- What it targets
Support for the nervous system's own recovery processes — not treatment of neurodegenerative disease and not a replacement for emergency care.
- Honest expectations
The result depends heavily on the starting state and is not guaranteed; the MDT gives a realistic prognosis.
Safety
Risks, tolerability and contraindications
Openness about safety is part of a responsible approach.
- Built on low-risk cells
MSCs with low immunogenicity are used; immunological risks are minimal.
- Tolerability
Brief general reactions are possible (for example, a mild temperature rise); procedures are performed under supervision.
- Specialist care first
Acute and unstable conditions require emergency medical care first; the cellular part comes only when appropriate.
- When it isn't performed
Suitability and contraindications are determined individually by the MDT after neuro-diagnostics.
Cost
Indicative cost
Up to approx. ¥178,000 (≈ $24,700), within a rehabilitation programme
The exact cost is determined only after diagnostics — the programme is tailored individually, by indication. Payment is made directly to the cluster's clinic, by official invoice. All prices →
Diagnostics — the required first step
Every programme begins with a consultation and an accurate diagnosis (check-up). Treatment does not start without assessing indications and contraindications.
Questions
FAQ — Neuroregeneration
Yes. Every programme begins with a consultation and diagnostics (check-up). No therapy starts without an accurate diagnosis and assessment of contraindications — that is the basis of safety.
As a rule, part of comprehensive rehabilitation. Acute and severe conditions require specialist medical care first.
Only by an individual specialist assessment after diagnostics. The method is not a treatment for these diseases and does not guarantee a result.
Usually 4–6 weeks, with 1–3 cell administrations. The MDT sets the exact plan.
Acute and unstable conditions require specialist emergency care first. The cellular programme is considered when the condition allows — as assessed by the MDT.
The programme length, the number of administrations and the volume of rehabilitation. See the Pricing page for a guide; the estimate is formed after diagnostics and paid directly to the clinic.
Discuss the programme with a coordinator
Tell us your situation and medical goal — we'll advise which documents help prepare a preliminary review and what the next steps could be.